<VariationArchive RecordType="classified" VariationID="2502" VariationName="NM_000127.3(EXT1):c.1664dup (p.Asn555fs)" VariationType="Duplication" Accession="VCV000002502" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2019-05-02" MostRecentSubmission="2019-05-02">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="17541" VariationID="2502">
      <GeneList>
        <Gene Symbol="EXT1" FullName="exostosin glycosyltransferase 1" GeneID="2131" HGNC_ID="HGNC:3512" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8q24.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="117794490" stop="118111826" display_start="117794490" display_stop="118111826" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="118811601" stop="119124057" display_start="118811601" display_stop="119124057" Strand="-" />
          </Location>
          <OMIM>608177</OMIM>
          <Haploinsufficiency last_evaluated="2020-06-17" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=EXT1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-06-17" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=EXT1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000127.3(EXT1):c.1664dup (p.Asn555fs)</Name>
      <CanonicalSPDI>NC_000008.11:117812929:TT:TTT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>8q24.11</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="117812929" stop="117812930" display_start="117812929" display_stop="117812930" variantLength="1" positionVCF="117812929" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="118825168" stop="118825169" display_start="118825168" display_stop="118825169" variantLength="1" positionVCF="118825168" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
      </Location>
      <ProteinChange>N555fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000127.2" sequenceAccession="NM_000127" sequenceVersion="2" change="c.1664dupA">
            <Expression>NM_000127.2:c.1664dupA</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.118825170dup" Assembly="GRCh37">
            <Expression>NC_000008.10:g.118825170dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.117812931dup" Assembly="GRCh38">
            <Expression>NC_000008.11:g.117812931dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007455.2" sequenceAccession="NG_007455" sequenceVersion="2" change="g.303890dup">
            <Expression>NG_007455.2:g.303890dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000127.3" sequenceAccession="NM_000127" sequenceVersion="3" change="c.1664dup" MANESelect="true">
            <Expression>NM_000127.3:c.1664dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000118.2" sequenceAccession="NP_000118" sequenceVersion="2" change="p.Asn555fs">
            <Expression>NP_000118.2:p.Asn555fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_493" sequenceAccession="LRG_493">
            <Expression>LRG_493:g.303890dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="608177.0011" DB="OMIM" />
        <XRef Type="rs" ID="1586993159" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="ClinGen" Type="public">ClinGen staff contributed the HGVS expression for this variant.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000127.3(EXT1):c.1664dup (p.Asn555fs) AND Exostoses, multiple, type 1" Accession="RCV000002608" Version="3">
        <ClassifiedConditionList TraitSetID="52386">
          <ClassifiedCondition DB="MedGen" ID="CN263289">Exostoses, multiple, type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2004-08-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2004-08-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-05-02" MostRecentSubmission="2019-05-02">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15253765</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="52386" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="43650" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">EXOSTOSES, MULTIPLE, TYPE I</ElementValue>
                <XRef Type="MIM" ID="133700" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608177.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608177.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608177.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608177.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608177.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608177.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608177.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608177.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608177.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608177.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608177.0012" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Exostoses, multiple, type 1</ElementValue>
                <XRef ID="MONDO:0007585" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EXT1</ElementValue>
                <XRef Type="MIM" ID="133700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hereditary multiple osteochondromas (HMO), previously called hereditary multiple exostoses (HME), is characterized by growths of multiple osteochondromas, benign cartilage-capped bone tumors that grow outward from the metaphyses of long bones. Osteochondromas can be associated with a reduction in skeletal growth, bony deformity, restricted joint motion, shortened stature, premature osteoarthrosis, and compression of peripheral nerves. The median age of diagnosis is three years; nearly all affected individuals are diagnosed by age 12 years. The risk for malignant degeneration to osteochondrosarcoma increases with age, although the lifetime risk for malignant degeneration is low (~2%-5%).</Attribute>
                <XRef ID="NBK1235" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301413</ID>
                <ID Source="BookShelf">NBK1235</ID>
              </Citation>
              <XRef ID="CN263289" DB="MedGen" />
              <XRef ID="MONDO:0007585" DB="MONDO" />
              <XRef Type="MIM" ID="133700" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="22766" SubmissionDate="2019-04-29" DateLastUpdated="2019-05-02" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="608177.0011_EXOSTOSES, MULTIPLE, TYPE I" title="EXT1, 1-BP INS, 1664A_EXOSTOSES, MULTIPLE, TYPE I" />
        <ClinVarAccession Accession="SCV000022766" DateUpdated="2019-05-02" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2004-08-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members of a large consanguineous Pakistani family with multiple exostoses type I (EXT1; 133700), Faiyaz-Ul-Haque et al. (2004) identified a 1-bp insertion (1664insA) in exon 8 of the EXT1 gene, predicted to produce a frameshift at codon 555 resulting in a premature termination 10 codons downstream. Bilateral overriding of the second or third toes was observed in all affected individuals except for 1 asymptomatic female and 1 mildly affected female. No unaffected individuals had this feature, which was present at birth and allowed earlier diagnosis of the disorder.</Attribute>
              <Citation>
                <ID Source="PubMed">15253765</ID>
              </Citation>
              <XRef DB="OMIM" ID="133700" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EXT1" />
          </GeneList>
          <Name>EXT1, 1-BP INS, 1664A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 1664A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="608177.0011" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">EXOSTOSES, MULTIPLE, TYPE I</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="22766" TraitType="Disease" MappingType="Name" MappingValue="EXOSTOSES, MULTIPLE, TYPE I" MappingRef="Preferred">
        <MedGen CUI="CN263289" Name="Exostoses, multiple, type 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

